|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
06-09-2010, 10:27 PM
|
|||
|
|||
Radium-223 Chloride (Alpharadin) Shows Potential In Tough-To-Treat Prostate Cancer
CHICAGO - The investigational alpha-pharmaceutical radium-223 chloride (Alpharadin) appears to confer multiple benefits in men with metastatic castration-resistant prostate cancer (CRPC), researchers announced at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Results in two open-label phase 1 trials and three double-blind phase II trials showed that the agent ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| A Potential Chemotherapeutic Drug To Treat Hepatocellular Carcinoma | cancerfr | Adrenocortical Carcinoma | 0 | 08-02-2010 03:10 PM |
| Radium-223 Shows Early Promise In Prostate Cancer Patients With Bone Metastases | cancerfr | Bone Cancer | 0 | 06-25-2010 10:46 PM |
| Progress Made Against Tough-to-Treat Biliary Tract Cancers | cancerfr | Gallbladder Cancer | 0 | 04-09-2010 03:02 AM |
| Progress Made Against Tough-to-Treat Biliary Tract Cancers | cancerfr | Bladder Cancer | 0 | 04-08-2010 06:11 PM |
| Progress Made Against Tough-to-Treat Biliary Tract Cancers | cancerfr | Gallbladder Cancer | 0 | 04-08-2010 11:32 AM |
Linear Mode
